Disclosures for "Continuous, Subcutaneous Apomorphine Infusion for Persistent Motor Fluctuations in Parkinson’s Disease: Full results of the AP2-3000 open-label study")
-
The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
-
Dr. Ceresoli-Borroni has nothing to disclose.
-
Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bexion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
-
Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Health. Dr. Pahwa has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Kinetics. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allevion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Photopharmics. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wren. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Biohaven. The institution of Dr. Pahwa has received research support from Boston Scientific. The institution of Dr. Pahwa has received research support from EIP. The institution of Dr. Pahwa has received research support from Global Kinetics. The institution of Dr. Pahwa has received research support from Amneal. The institution of Dr. Pahwa has received research support from Neuraly. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Pharma 2B. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theranexus. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Voyager. The institution of Dr. Pahwa has received research support from Neuroderm.
-
Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US WorldMeds. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adamas. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accorda. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for US WorldMeds / Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Accorda. An immediate family member of Dr. Agarwal has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ariz Precision Medicine. Dr. Agarwal has stock in Arbutus Biopharma. Dr. Agarwal has stock in Affimed. Dr. Agarwal has stock in Agile Therapeutics. Dr. Agarwal has stock in Applied Genetic Technologies. Dr. Agarwal has stock in Alderya Therpeutics. Dr. Agarwal has stock in Altimmune. Dr. Agarwal has stock in Amryt Pharma. Dr. Agarwal has stock in Aptynix Inc. Dr. Agarwal has stock in Aquestive Therapeutics. Dr. Agarwal has stock in Actinium Therapeutics. Dr. Agarwal has stock in Atossa Therapeutics. Dr. Agarwal has stock in Antares Pharma. Dr. Agarwal has stock in Aurinia Pharmaceuticals. Dr. Agarwal has stock in Catalyst Biosciences. Dr. Agarwal has stock in Cellectar Biosciences. Dr. Agarwal has stock in Corcept Therapeutics. Dr. Agarwal has stock in Catalyst Pharmaceuticals. Dr. Agarwal has stock in Curis Inc. Dr. Agarwal has stock in Citius Pharmaceuticals. Dr. Agarwal has stock in Eigor Biopharma. Dr. Agarwal has stock in Epizyme . Dr. Agarwal has stock in Eyegate Pharma. Dr. Agarwal has stock in Fortress Biotech. Dr. Agarwal has stock in Gevo Inc. Dr. Agarwal has stock in Genprex Inc. Dr. Agarwal has stock in G1 Therapeutics. Dr. Agarwal has stock in Idera Pharmaceuticlas. Dr. Agarwal has stock in Jounce Therapeutics. Dr. Agarwal has stock in Kadmon HLDS. Dr. Agarwal has stock in Lightpath technologies. Dr. Agarwal has stock in Lantronix Inc. Dr. Agarwal has stock in Marinus Pharnmaceuticals. Dr. Agarwal has stock in OVID Therapeutics. Dr. Agarwal has stock in Phasebio Pharmaceutics. Dr. Agarwal has stock in Pieris Pharmaceuticals. Dr. Agarwal has stock in Recro Pharma. Dr. Agarwal has stock in Rigel Pharma. Dr. Agarwal has stock in SIGA Technologies. Dr. Agarwal has stock in Soleno Therapeutics. Dr. Agarwal has stock in TG Therapeutics. Dr. Agarwal has stock in Trinity Biotech. Dr. Agarwal has stock in Yumanity Therapeutics. The institution of Dr. Agarwal has received research support from AbbVie, Inc.. The institution of Dr. Agarwal has received research support from Acadia Pharmaceuticals. The institution of Dr. Agarwal has received research support from Adamas. The institution of Dr. Agarwal has received research support from Annexon. The institution of Dr. Agarwal has received research support from Astellas. The institution of Dr. Agarwal has received research support from Auspex. The institution of Dr. Agarwal has received research support from Axial Biotherapeutics. The institution of Dr. Agarwal has received research support from Biogen Idec. The institution of Dr. Agarwal has received research support from Biotie/inVentiv Health. The institution of Dr. Agarwal has received research support from Cala Health. The institution of Dr. Agarwal has received research support from Centogene AG. The institution of Dr. Agarwal has received research support from Cerecor Inc.. The institution of Dr. Agarwal has received research support from Cerevel. The institution of Dr. Agarwal has received research support from Chase Therapeutics. The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Civitas. The institution of Dr. Agarwal has received research support from Cynapsus. The institution of Dr. Agarwal has received research support from Dong-A ST. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from Enterin Inc.. The institution of Dr. Agarwal has received research support from Impax. The institution of Dr. Agarwal has received research support from Intec / PRA. The institution of Dr. Agarwal has received research support from Jazz Pharmaceuticals, Inc.. The institution of Dr. Agarwal has received research support from Lundbeck. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Merck & Co. The institution of Dr. Agarwal has received research support from Neurally, Inc.. The institution of Dr. Agarwal has received research support from Dystonia Medical Research. The institution of Dr. Agarwal has received research support from NIH/NWern Univ/PSG. The institution of Dr. Agarwal has received research support from Pfizer. The institution of Dr. Agarwal has received research support from Pharma Two B. The institution of Dr. Agarwal has received research support from Prilenia Therapeutics. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Sanofi. The institution of Dr. Agarwal has received research support from Sun Pharma. The institution of Dr. Agarwal has received research support from Teva. The institution of Dr. Agarwal has received research support from Theravance Biopharma. The institution of Dr. Agarwal has received research support from Titan Pharmaceuticals. The institution of Dr. Agarwal has received research support from US WorldMeds. The institution of Dr. Agarwal has received research support from US WorldMeds / Solstice.
-
Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbive.
-
Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Hui has received research support from Roche. The institution of Dr. Hui has received research support from Abbvie. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Roundtable speaker with Medscape .
-
Dr. Dashtipour has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal, Abbvie, Acorda, Acadia, Ipsen, Supernus, Sunovion, Neurocrine, Teva. Dr. Dashtipour has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal, Abbvie, Acadia, Supernus. Dr. Dashtipour has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Amneal, Acorda, Abbvie, Ipsen, Teva, Neurocrine, SupernusPD, sunovion .
-
Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for adamas. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
-
Peibing Qin has nothing to disclose.
-
Dr. Nasser has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc..
-
Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda Therapeutics. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for US WorldMeds LLC. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin Inc. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe-NeuroDerm Neuropharma. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bukwang Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. LeWitt has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for CLINICAL NEUROPHARMACOLOGY.